CSBR:NASDAQ
Champions Oncology Inc
4,34 $
arrow_downward
-1,36%(-0,060) 1D
20 қар., 16:00:00 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSBR...
Open
4,45 $
High
4,45 $
Low
4,34 $
Mkt. cap
60,41 млн
Avg. vol.
6,97 мың
Volume
8,94 мың
52-wk high
8,31 $
52-wk low
4,34 $
EPS
-0,08 $
Beta
0,47
Shares outstanding
13,92 млн
No. of employees
217
Open
4,45 $
High
4,45 $
Low
4,34 $
Mkt. cap
60,41 млн
Avg. vol.
6,97 мың
Volume
8,94 мың
52-wk high
8,31 $
52-wk low
4,34 $
EPS
-0,08 $
Beta
0,47
Shares outstanding
13,92 млн
No. of employees
217
News stories
From web sources and news partners
Yahoo Finance
·
58 минут бұрын
T-Bills Are Beating the Nasdaq, S&P 500 and Dow This Year
24/7 Wall St.
·
19 минут бұрын
The S&P 500 Is Having the Longest Losing Streak Since February 2020
Beinsure
·
2 сағат бұрын
Vanguard S&P 500 ETF: How investing in VOO could build a $1 mn portfolio
Trefis
·
12 сағат бұрын
S&P 500 Movers | Winners: GPN, GIS, MKC | Losers: BE, NVDA, LITE
Profile
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
About Champions Oncology Inc
CEO-
Employees217
Founded2007
HeadquartersХаккенсак, Нью-Джерси, Америка Құрама Штаттары
SectorHealth Care
Industry-
Websitechampionsoncology.com